[go: up one dir, main page]

IL132570A0 - Cox-2 selective carprofen for treating pain and inflammation in dogs - Google Patents

Cox-2 selective carprofen for treating pain and inflammation in dogs

Info

Publication number
IL132570A0
IL132570A0 IL13257098A IL13257098A IL132570A0 IL 132570 A0 IL132570 A0 IL 132570A0 IL 13257098 A IL13257098 A IL 13257098A IL 13257098 A IL13257098 A IL 13257098A IL 132570 A0 IL132570 A0 IL 132570A0
Authority
IL
Israel
Prior art keywords
carprofen
cox
dogs
inflammation
selective
Prior art date
Application number
IL13257098A
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL132570A0 publication Critical patent/IL132570A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
IL13257098A 1997-05-05 1998-05-01 Cox-2 selective carprofen for treating pain and inflammation in dogs IL132570A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4563597P 1997-05-05 1997-05-05
PCT/IB1998/000662 WO1998050033A1 (en) 1997-05-05 1998-05-01 Cox-2 selective carprofen for treating pain and inflammation in dogs

Publications (1)

Publication Number Publication Date
IL132570A0 true IL132570A0 (en) 2001-03-19

Family

ID=21939053

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13257098A IL132570A0 (en) 1997-05-05 1998-05-01 Cox-2 selective carprofen for treating pain and inflammation in dogs

Country Status (32)

Country Link
EP (1) EP0988034A1 (en)
JP (1) JP2000513020A (en)
KR (2) KR20040004406A (en)
CN (1) CN1255059A (en)
AP (1) AP9801234A0 (en)
AR (2) AR011726A1 (en)
AU (1) AU6932198A (en)
BG (1) BG103852A (en)
BR (1) BR9808720A (en)
CA (1) CA2288759A1 (en)
DZ (1) DZ2479A1 (en)
EA (1) EA003696B1 (en)
GT (1) GT199800063A (en)
HR (1) HRP980244A2 (en)
HU (1) HUP0001286A3 (en)
ID (1) ID21311A (en)
IL (1) IL132570A0 (en)
IS (1) IS5220A (en)
MA (1) MA26491A1 (en)
NO (1) NO995389L (en)
NZ (1) NZ500183A (en)
OA (1) OA11213A (en)
PA (1) PA8450601A1 (en)
PE (1) PE72599A1 (en)
PL (1) PL337003A1 (en)
SK (1) SK148199A3 (en)
TN (1) TNSN98059A1 (en)
TW (1) TW590773B (en)
UY (1) UY24989A1 (en)
WO (1) WO1998050033A1 (en)
YU (1) YU55899A (en)
ZA (1) ZA983722B (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245797B1 (en) 1997-10-22 2001-06-12 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
AU2003204888B2 (en) * 1998-05-22 2005-07-28 Pfizer Products Inc. Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives
US6506785B2 (en) 1998-05-22 2003-01-14 Pfizer, Inc. Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
JP2002528413A (en) * 1998-10-23 2002-09-03 メルク フロスト カナダ アンド カンパニー Combination comprising type E prostaglandin ligand and COX-2 selective inhibitor and method of use
JP2002538189A (en) * 1999-03-10 2002-11-12 ジー.ディー.サール アンド カンパニー Administration method and composition of cyclooxygenase-2 inhibitor
WO2001034204A1 (en) * 1999-11-11 2001-05-17 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
CA2407469A1 (en) * 2000-05-15 2001-11-22 Merck Frosst Canada & Co. Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor
AU6837701A (en) 2000-06-13 2001-12-24 American Home Prod Analgesic and anti-inflammatory compositions containing cox-2 inhibitors
DE10032132A1 (en) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermal therapeutic system containing non-steroidal anti-inflammatory drugs with selective COX-2 inhibition
DE60137335D1 (en) 2000-08-07 2009-02-26 Univ Vanderbilt Detection of COX-2 activity and anandamide metabolites
US20040209959A1 (en) * 2001-07-16 2004-10-21 Edward Hogestatt Congeners of acetaminophen and related compounds as substrates for fatty acid conjugation and their use in treatment of pain, fever and inflammation
DE602004002832T2 (en) 2003-05-07 2007-06-06 Osteologix A/S TREATMENT OF CARTILAGE / BONE DISEASES WITH WATER-SOLUBLE STRONTIUM SALTS
CA2533101A1 (en) * 2003-07-31 2005-02-03 Pharmacia & Upjohn Company Llc Dispersible formulation of an anti-inflammatory agent
CA2608010A1 (en) * 2005-05-20 2006-11-23 Pfizer Limited Synergistic combinations of non-steroidal antiinflammatory drugs with alpha-delta-ligands
CN103120653B (en) 2007-04-04 2015-09-30 希格默伊德药业有限公司 A kind of combination of oral medication
CA2685118C (en) 2007-04-26 2016-11-01 Sigmoid Pharma Limited Manufacture of multiple minicapsules
JP5640079B2 (en) 2009-05-18 2014-12-10 シグモイド・ファーマ・リミテッドSigmoid Pharma Limited Oil droplet-containing composition
CN102573802A (en) 2009-08-12 2012-07-11 希格默伊德药业有限公司 Immunomodulatory compositions comprising a polymer matrix and an oil phase
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
US12109218B2 (en) 2014-12-09 2024-10-08 Aratana Therapeutics, Inc. Compositions of grapiprant and methods for using the same
DK3113774T3 (en) * 2014-03-06 2022-03-07 Elanco Animal Health Incorporated COMPOSITIONS OF GRAPIPRANT AND METHODS OF USING IT
PT3215127T (en) 2014-11-07 2021-02-10 Sublimity Therapeutics Ltd Compositions comprising cyclosporin
EP3242557A4 (en) * 2015-01-09 2018-09-05 Jaguar Health, Inc. Methods of treating diarrhea in companion animals
US20230174485A1 (en) * 2020-03-25 2023-06-08 Sri International Lipoxygenase inhibitors
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
KR102404883B1 (en) 2020-11-30 2022-06-07 (주)이노보테라퓨틱스 Pharmaceutical composition for preventing or treating keloid or hypertrophic scar comprising Benzbromarone

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896145A (en) * 1972-07-24 1975-07-22 Hoffmann La Roche Carbazoles
CA1319886C (en) * 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions

Also Published As

Publication number Publication date
SK148199A3 (en) 2001-09-11
PL337003A1 (en) 2000-07-31
BG103852A (en) 2000-06-30
PE72599A1 (en) 1999-08-12
TW590773B (en) 2004-06-11
OA11213A (en) 2003-07-14
AR011726A1 (en) 2000-08-30
GT199800063A (en) 1999-10-26
CA2288759A1 (en) 1998-11-12
HUP0001286A3 (en) 2000-12-28
KR20040004406A (en) 2004-01-13
IS5220A (en) 1999-10-19
MA26491A1 (en) 2004-12-20
NZ500183A (en) 2002-04-26
BR9808720A (en) 2000-07-11
NO995389L (en) 2000-01-04
PA8450601A1 (en) 2000-05-24
EA003696B1 (en) 2003-08-28
AU6932198A (en) 1998-11-27
DZ2479A1 (en) 2003-02-01
AR039628A2 (en) 2005-03-02
HRP980244A2 (en) 1999-02-28
UY24989A1 (en) 2001-10-25
ID21311A (en) 1999-05-20
EA199900895A1 (en) 2000-06-26
JP2000513020A (en) 2000-10-03
EP0988034A1 (en) 2000-03-29
AP9801234A0 (en) 1999-11-04
TNSN98059A1 (en) 2005-03-15
ZA983722B (en) 1999-11-04
WO1998050033A1 (en) 1998-11-12
NO995389D0 (en) 1999-11-04
YU55899A (en) 2003-08-29
HUP0001286A2 (en) 2000-11-28
CN1255059A (en) 2000-05-31
KR20010012300A (en) 2001-02-15

Similar Documents

Publication Publication Date Title
IL132570A0 (en) Cox-2 selective carprofen for treating pain and inflammation in dogs
HUP0004170A3 (en) Methods and materials for treating and preventing inflammation ofmucosal tissue
EP1065978A4 (en) Implantable therapeutic device and method
GB2346809B (en) Heel care device and method
EP1200086A4 (en) Methods for treating or preventing pain and anxiety
IL132758A0 (en) Methods for treating inflammation and inflammatory diseases using padprt
EP1016450A4 (en) Mixing method and mixing device
GB9919113D0 (en) Hair treatment device and method
IL138062A0 (en) Veterinary delivery device and method
EP1049107A4 (en) Substance activating method and device
EP0965840A4 (en) Method for analyzing annexin v in urine and use thereof
EP1099370A4 (en) Livestock raising facility and method
GB9809448D0 (en) Treatment device and method
HUP0004372A3 (en) Water treatment method and device
BR9702162A (en) Skin solution for direct application for antiparasitic use in cattle and sheep
IL132867A0 (en) Epilation method and device
AU5871898A (en) Microparticles and their use in cancer treatment
GB2312366B (en) Hoof cleaning and treatment device
GB9707949D0 (en) Water treatment and delivery apparatus
GB9924719D0 (en) Water treatment and delivery apparatus
ZA98793B (en) Microparticles and their use in cancer treatment
GB9818018D0 (en) Microparticles and their use in therapy
GB9907879D0 (en) Hair treatment device and method
TW424591U (en) Polylone waste treatment and regeneration device
GB9718062D0 (en) Hair treatment device and method